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 Abstract 
Background: We know very little about the microbiota inhabiting the upper female 
reproductive tract and how it impacts on fertility.  
Aims: This pilot study aimed to examine the vaginal, cervical, and endometrial microbiota 
for women with a history of infertility compared to women with a history of fertility.  
Materials and Methods: Using a retrospective case-control study design, women were 
recruited for collection of vaginal, cervical and endometrial samples. The microbiota 
composition was analysed by 16S rRNA gene amplification and endometrial expression of 
selected human genes by qRT-PCR. 
Results:  Sixty-five specimens from the reproductive tract of 31 women were successfully 
analysed using 16S rRNA gene amplicon sequencing (16 controls and 15 cases). The 
dominant microbial community members were consistent in the vagina and cervix, and 
generally consistent with the endometrium although the relative proportions varied. We 
detected three major microbiota clusters that did not group by tissue location or case-control 
status. There was a trend that infertile women more often had Ureaplasma in the vagina and 
Gardnerella in the cervix. Testing for the expression of selected genes in the endometrium 
did not show evidence of correlation with case-control status, or with microbial community 
composition, although Tenascin-C expression correlated with a history of miscarriage.  
Conclusions: There is a need for further exploration of the endometrial microbiota, and how 




The vaginal microbiota has an established role in female reproductive tract physiology, 
pathogen defense, and function [1, 2]. In 2011, the vaginal microbiota of reproductive-age 
women was characterized by 16S rRNA gene amplicon sequencing, leading to the 
identification of five community state types (CST) [3]. These were defined by the presence or 
absence of a dominant Lactobacillus spp., including CST I: Lactobacillus (L.) crispatus, II: L. 
gasseri, III: L iners, IV: a diverse array of strict and facultative anaerobes lacking a dominant 
Lactobacillus spp., and V: L. jensenii [3]. Longitudinal analysis subsequently showed that the 
vaginal microbiota is highly dynamic, with changes observed after sexual contact, menses, 
douching, and lubricant use [4]. Although, a separate study using CPN60 profiling reported 
community stability throughout the menstrual cycle [5].  
There are few studies of the upper reproductive tract microbiota. Analysis of vaginal, 
cervical, and endometrial specimens after insertion of an intrauterine levonorgestrel device 
(LNG IUS) found a microbiota shift towards Lactobacillus crispatus [6]. Species-specific PCR 
analysis of hysterectomy samples demonstratedthat the upper reproductive tract microbiota did 
not correlate with selected host inflammatory markers [7]. Upon examining the tip of the 
transfer catheter used for embryo transfer during IVF [8], a lower relative abundance of 
Pseudomonas spp. and Flavobacterium spp. was present in women who proceeded to 
successful pregnancy [8]. The diversity of the vaginal microbiota in women undergoing in vitro 
fertilization embryo transfer was higher for women who had a live birth from the cycle [9]. 
The presence of a non-Lactobacillus dominant microbiota in the endometrium correlated with 
IVF embryo transfer failure [10]. While these reports support that the reproductive tract 
microbiota impacts fertility and pregnancy outcomes, much remains to be tested, such as 
examining infertility or pregnancy outcomes in the context of specific taxa, species level 
analysis, or the community state types/profiles. In this pilot study, we sought to examine the 
possible association of the reproductive tract microbiota with women who have a current or 
recent past history of infertility.  
Method 
Study design 
We designed a pilot case-control study of the reproductive tract microbiota of women with a 
recent previous or current history of infertility (Cases), compared to women with no history of 
infertility (Controls) (Table 1). Women already undergoing hysteroscopy for a variety of 
reasons, excluding suspected cancer, were invited to participate.  Participants categorized as 
Cases were currently attending gynecological or fertility care, or attending for other 
gynecological reasons but had a recent previous history of infertility that required assisted 
reproductive technologies. Inclusion criteria for Cases were women who had reported greater 
than a year of trying to achieve pregnancy, and who currently or previously required assisted 
reproductive technologies to achieve pregnancy. Five women in the infertile group were 
undergoing treatment for infertility at the time of recruitment; the remaining ten were having 
treatment for other gynecological reasons, having previously required assisted reproductive 
technologies to achieve pregnancy. Given the retrospective and pilot nature of this study, type 
of infertility was not an inclusion or exclusion criteria. Participants recruited to the Control 
group were women who had a history of pregnancies with no need for assisted reproductive 
technologies, and who were attending gynecological care for a hysteroscopy procedure for 
gynecological care (hysteroscopy for an IUD (IUS) change, or hysterectomy, excluding 
suspected reproductive cancers). Gynecological and obstetric histories were collected using a 
self-completed questionnaire. Several participants who were recruited and consented to the 
study, but were 50 years or over, were used for extraction method validation and were not 
included in the analysis. Participants whose vaginal and/or other specimens did not pass 
extraction quality assessment were not included for sequencing. 
At the time of hysteroscopy in the operating theatre, a sterile speculum was inserted into the 
vagina, and swabs collected from the posterior fornix and the endocervical canal. The vagina 
was then prepared for surgery with betadine antiseptic surgical solution. An endometrial biopsy 
was collected using an endometrial curette and stored in 0.5 ml of RNALater. Study samples 
were immediately taken to the on-site Tissue Bank and frozen at -80°C, with the exception of 
the endometrial sample that was incubated overnight at 4°C to allow the preservative buffer to 
penetrate the tissue, and then frozen at -80°C the following day.   
In addition to comparing participant microbiota profiles based on case and control 
categories, we also analyzed other aspects of their gynecological history. These included the 
type of contraceptive used, any history of miscarriages, any history of endometriosis, and age 
. For contraceptives, we grouped the participants into the categories of i) pill (oral 
contraceptives), ii) LNG IUS (intrauterine levonorgestrel device) or iii) other, based on self-
reporting. The other contraceptive category included methods such as rhythm, condoms, tubal 
ligation or no use of active contraception at all. These were classified together (Other) because 
we assumed similar implications for endometrial gene expression as compared to hormonal 
contraceptives. We used the following age groups for categorical analysis: 28-33, 34-39, 40-
45, and 46-49 years old.   
Ethics approval and consent to participate 
Ethical approval to conduct this study was granted by the Uniting Care Health Human Research 
Ethics committee (Approval number 1227), Queensland University of Technology Human 
Research Ethics Committee (Approval number 1300000004), and University of Technology 
Sydney Human Research Ethics Committee (Approval number 2015000700). Participants 
provided informed written consent prior to participation in the study. 
Availability of data and material 
The dataset is available in SRA database under accession number: PRJEB18626. 
Microbiota processing, amplification and analysis 
The protocols for sample processing, 16S rRNA gene amplification, sequencing, statistical 
analysis of microbiota data, PCR for Ureaplasma, and qPCR for endometrial gene expression 
are provided as Supplementary Material 1.  
Statistical analysis 
To identify differences between cases and controls, we performed a non-parametric t-test using 
species level classifications [11], fully described in the Supplementary material 1. Plots were 
generated using the R Package Phyloseq v1.12.2 [12]. We compared the proportions or 
distributions of the demographic (age), obstetric, and gynecological factors between the case 
and control groups using SPSS (specific test indicated with the results). 
 
Results 
Case-control groups were comparable for gynecological factors, although age was 
significantly different   
This was a retrospective pilot case-control examination of the reproductive tract microbiota for 
women with a current or past history of infertility needing assisted reproductive technologies 
to conceive (Cases), compared to women with no history of infertility (Controls) (Table 1). 
The groups had similar proportions of the types of contraceptives in use, endometriosis, and 
miscarriage (Table 1). However, the number of live births, seeking pregnancy, and age were 
significantly different between the Cases and Controls.  
The endometrial microbiota appeared to have different relative abundances of 
microbiota to that in the vagina and cervix in some participants   
16S rRNA gene amplicon sequencing was performed on DNA isolated from the vagina, cervix, 
and endometrium, for samples where this could be successfully extracted (summarized in Table 
2 and Supplementary Table S2). The sequence depth per sample was variable, with the highest 
number of filtered sequences obtained from vaginal (mean=88,302) and cervical 
(mean=95,401) samples (Supplementary Table S2). Endometrial samples produced fewer 
reads ( average of 7,815 per sample).  
 
The genus Lactobacillus was most frequently observed (Figure 1). The most abundant 
taxonomic units were the same in both cervical and vaginal specimens for all 24 of the 33 
women where both were sequenced (Figure 1). In women with sequences from both the 
endometrium and vagina, half had some differences in the proportions of the most abundant 
taxa relative to the vagina. A principal coordinates analysis of the Jensen-Shannon Divergence 
showed no grouping of specimens by reproductive site, age, case-control status 
(Supplementary data Figure S1). Similarly, Alpha Diversity analysis showed a variety of 
richness across the sites and case-control status with no clear associations (Supplementary data 
Figure S1). 
 
Community clusters were analyzed using a cluster dendrogram [3] that is based on dominant 
or absent Lactobacillus species (Figure 2). Microbiota profiles were distributed across these 
community state types, with three dominant clusters apparent. Community state type I (CSTI; 
L. crispatus dominant), CSTIII (L. iners dominant), and CSTIV were most common. Generally, 
each individual’s specimens (vaginal, cervical, and endometrial) clustered together with the 
exception of three endometrial samples and one vaginal sample that featured a mix of 
Corynebacterium, and Propionibacterium, that formed a cluster. 
 
There were possible sub-clusters within the CSTIV (with CST II or dominant L. gasseri within 
this group). These were dominated by Gardnerella vaginalis (with Prevotella in some cases) 
(consistent with CSTIV [3], CST IV-B [4]),  or Streptococcus agalactiae /Streptocococcus 
anginosus were dominant (consistent with CST IV-A [4]); or  Bifidobacterium  (also as 
described in another study [5]). However, while consistent with previously reported sub-
clusters, these clusters would need a larger sample size to resolve.  
 
Women with a past history of infertility showed a trend towards having Ureaplasma spp. 
in the vagina and Gardnerella in the cervix 
We observed a trend for two organisms to be more abundant or prevalent in the Cases 
(Ureaplasma spp., p=0.042 (vagina) and G. vaginalis, p=0.044 (cervix); unadjusted). A 
Ureaplasma-specific PCR was used to further confirm that all five positive samples contained 
Ureaplasma parvum (Supplementary Figure S2 and S3). Four of the five women with a history 
of infertility (Cases) colonised with Ureaplasma also had a vaginal CST III dominated by L. 
iners (p= 0.015; unadjusted for multiple testing).  
 
Endometrial gene expression significantly correlated with a history of miscarriage and 
contraceptive use, but not with a history of infertility or microbiota composition 
We next assessed endometrial expression of selected genes with known endometrial function 
(IL-1, IL-6, IL-8, TN-C, TNF, and SDC1). There were no significant differences in the 
expression of these genes in relation to case-control status (Figure 3A, B). High expression of 
TN-C grouped in two clusters on a linkage dendrogram and was higher in women with a history 
of miscarriage (p<0.001, Figure 3C). IL-6 expression levels were higher in LNG IUS users 
(p=0.05), whereas SDC1 was significantly lower in LNG IUS users compared to OCP users 
(p<0.01, Figure 3D).  
Discussion 
The objective of this pilot study was to examine the reproductive tract microbiota (vagina, 
cervix, and endometrium) in women with a history of needing fertility treatment for pregnancy 
compared to fertile controls. We observed some differences in the upper reproductive tract 
(endometrium) compared to the vagina and cervix within individual participants. Furthermore, 
we showed a trend of Gardnerella in the cervix and Ureaplasma in the vagina being associated 
with women with a history of infertility, adding further support to the case that the microbiota 
should be further evaluated for relevance to fertility and assisted reproductive treatment.  
Our study has a number of limitations that should be considered when interpreting these 
results. The time of fertility status is in the past, meaning the samples were not collected when 
the women were experiencing infertility/fertility. Also,the Control group were significantly 
older. Although three reproductive sites were sampled from each participant, inconsistencies 
in DNA extraction quality and/or sequence results limited the number of individuals with 
sequenced microbiota from all three sites. This may reflect the expected relatively lower 
numbers of bacteria in the endometrium, or could indicate difficulties in DNA extraction from 
this site. The sampling protocol specified the need to avoid the surface of the vaginal canal 
when removing the cervical/endometrial sample, however we do note the potential for cross 
contamination by this technique. Additionally, it is known that the vaginal microbiome (and 
presumably also the endometrial microbiome) is affected by ethnicity, age, pregnancy, sexual 
activity, smoking and exogenous hormones [13-17]. While we were not able to control for 
several of these factors in this pilot study, we recommend that any future large-scale studies 
should attempt to do so.  
In spite of these limitations, our findings are consistent with other published studies. 
Many individuals within this study had a dominant Lactobacillus species [3, 4]. The possible 
CSTIV sub-clusters may be significant for future research. A potential Bifidobacterium 
dominant sub-cluster was present in some endometrial samples, consistent with previous work 
[10]. Ureaplasma spp. (confirmed to be U. parvum) trended towards an association with 
infertility cases in the vagina and Gardnerella in the cervix. Ureaplasma spp. have been 
identified within the reproductive tracts of both fertile and infertile women [18, 19], and have 
been associated with preterm delivery (< 37 weeks of gestation) [20, 21] and other adverse 
pregnancy outcomes [21]. Here we provide a further association of Ureaplasma with infertility. 
The different abundance and presence/absence of taxa between the upper and lower genital 
tract specimens warrants further investigation, and our pilot study provides further baseline 
data to support the need for continued investigation into the endometrial microbiota. We 
speculate that the microbiome of the endometrium could be an important factor in unexplained 
infertility and/or repeat IVF cycle failures. 
There were no differences in endometrial gene expression of our selection of target 
genes based on case-control (fertility) status. TN-C had significantly high expression in 
participants with history of miscarriage, consistent with prior reports of an association with 
recurrent miscarriage [22-25]. We also detected the expected differences in IL-6 endometrial 
gene expression in women using LNG IUS compared to other contraceptives, as this has been 
previously reported [26, 27]. SDC1 has been reported as a marker of endometritis [28, 29], and 
here we found that SDC1 was significantly downregulated in LNG IUS users.  
Our pilot study supports that the endometrium microbiota is likely to have subtle yet 
important differences from the lower reproductive tract, and even the lower reproductive tract 
microbiota may have an impact on infertility. Future studies should include much larger sample 
sizes and prospective recruitment during fertility treatment. This will permit the monitoring of 
the microbiota and endometrial tissue responses during assisted reproductive treatment cycles. 
There is already a common practice of endometrial scratching (reviewed, [30]) during the 
menstrual cycle prior to embryo transfer. We propose scratching material could be harvested 
and tested for the endometrial microbiota and expression of select endometrial genes to 
optimize embryo transfer timing. Such an innovation will require larger, longitudinal studies 
of the reproductive tract microbiota on women undergoing fertility treatment during their 
cycles.  
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Figures 
Figure 1. The relative proportion of the 25 most abundant taxonomic assignments. The 
key is to the right. The results are grouped according to the participants’ Case-Control status 
(indicated at the top). The participant codes are below the graphs with each of the three 
specimen sites shown by row(indicated to the right: Vagina, Cervix, Endometrium). Only 
samples with more than 1,000 assembled and assigned sequences are displayed.  
Figure 2. Community state types dominated by Lactobacillus were present in the majority 
of specimens. Heat map showing the proportions of the top 20 most abundant taxonomic 
groups in the reproductive tract microbiota. Contraceptive, age, history of endometriosis, 
history of miscarriage, and case/control status are displayed above each sample (color keys are 
indicated to the right). Linkage clustering of the samples to the previously defined community 
state types (CST I, II, III and IV) [3] is shown at the top of the figure.  
Figure 3. Endometrial expression of six selected genes with known implications for 
endometrial pathology or function. (A) The dendrogram shows hierarchical linkage 
clustering of IL-1, IL-6, IL-8, SDC1, TN-C and TNF- gene expression. The relevant 
participant data are shown on the right; including case-control status, presence of Ureaplasma 
spp., age, miscarriage, and contraceptive (color keys indicated to the right). Colors represent 
the transformed mean Ct values for each specimen, calculated as 2-Ct. (B) miscarriage 
history, (C) contraceptives, (D) case-control status. Graphical representation of the expression 
levels of six genes of interest relative to the geometric mean of GAPDH and PPIA levels, 
grouped according to participant data. The data displayed on the Y-axis of each graph 
represents the transformed mean Ct values of each group, calculated as 2-Ct and multiplied 
by an arbitrary factor of 100. Error bars denote the standard error of the mean, while the X-
axis displays gene names. Bar color indicates participant grouping based on (A) Statistical 
testing of data was performed using either the Kruskall-Wallis or Mann-Whitney tests (* 
p<0.05; *** p=0.0006).  
 
Supplementary Data 
Supplementary Data are available for the manuscript. 
References 
1. Witkin, S.S., I.M. Linhares, and P. Giraldo, Bacterial flora of the female genital tract: 
function and immune regulation. Best Pract Res Clin Obstet Gynaecol, 2007. 21(3): p. 
347-54. 
2. Boris, S. and C. Barbes, Role played by lactobacilli in controlling the population of 
vaginal pathogens. Microbes Infect, 2000. 2(5): p. 543-6. 
3. Ravel, J., et al., Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci 
U S A, 2011. 108 Suppl 1: p. 4680-7. 
4. Gajer, P., et al., Temporal dynamics of the human vaginal microbiota. Sci Transl Med, 
2012. 4(132): p. 132ra52. 
5. Chaban, B., et al., Characterization of the vaginal microbiota of healthy Canadian 
women through the menstrual cycle. Microbiome, 2014. 2: p. 23. 
6. Jacobson, J.C., et al., Vaginal microbiome changes with levonorgestrel intrauterine 
system placement. Contraception, 2014. 90(2): p. 130-5. 
7. Mitchell, C.M., et al., Colonization of the upper genital tract by vaginal bacterial 
species in nonpregnant women. Am J Obstet Gynecol, 2015. 212(5): p. 611 e1-9. 
8. Franasiak, J.M., et al., Endometrial microbiome at the time of embryo transfer: next-
generation sequencing of the 16S ribosomal subunit. J Assist Reprod Genet, 2015. 
9. Hyman, R.W., et al., The dynamics of the vaginal microbiome during infertility therapy 
with in vitro fertilization-embryo transfer. J Assist Reprod Genet, 2012. 29(2): p. 105-
15. 
10. Moreno, I., et al., Evidence that the endometrial microbiota has an effect on 
implantation success or failure. Am J Obstet Gynecol, 2016. 
11. Caporaso, J.G., et al., QIIME allows analysis of high-throughput community 
sequencing data. Nat Methods, 2010. 7(5): p. 335-6. 
12. McMurdie, P.J. and S. Holmes, phyloseq: an R package for reproducible interactive 
analysis and graphics of microbiome census data. PLoS One, 2013. 8(4): p. e61217. 
13. Cherpes, T.L., et al., A delicate balance: risk factors for acquisition of bacterial 
vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, 
black race, and positive herpes simplex virus type 2 serology. Sex Transm Dis, 2008. 
35(1): p. 78-83. 
14. DiGiulio, D.B., et al., Temporal and spatial variation of the human microbiota during 
pregnancy. Proc Natl Acad Sci U S A, 2015. 112(35): p. 11060-5. 
15. Romero, R., et al., The composition and stability of the vaginal microbiota of normal 
pregnant women is different from that of non-pregnant women. Microbiome, 2014. 
2(1): p. 4. 
16. Ryckman, K.K., et al., Predicting risk of bacterial vaginosis: the role of race, smoking 
and corticotropin-releasing hormone-related genes. Mol Hum Reprod, 2009. 15(2): p. 
131-7. 
17. Sirota, I., S.M. Zarek, and J.H. Segars, Potential influence of the microbiome on 
infertility and assisted reproductive technology. Semin Reprod Med, 2014. 32(1): p. 35-
42. 
18. Kasprzykowska, U., et al., Colonization of the lower urogenital tract with Ureaplasma 
parvum can cause asymptomatic infection of the upper reproductive system in women: 
a preliminary study. Arch Gynecol Obstet, 2014. 289(5): p. 1129-34. 
19. Cassell, G.H., et al., Ureaplasma urealyticum intrauterine infection: role in prematurity 
and disease in newborns. Clin Microbiol Rev, 1993. 6(1): p. 69-87. 
20. Knox, C.L., et al., The role of Ureaplasma urealyticum in adverse pregnancy outcome. 
Aust N Z J Obstet Gynaecol, 1997. 37(1): p. 45-51. 
21. Sweeney, E.L., et al., Placental infection with Ureaplasma species is associated with 
histologic chorioamnionitis and adverse outcomes in moderate and late preterm infants. 
J Infect Dis, 2015. 
22. Harrington, D.J., et al., Tenascin is differentially expressed in endometrium and 
endometriosis. J Pathol, 1999. 187(2): p. 242-8. 
23. Jokimaa, V., et al., Altered expression of genes involved in the production and 
degradation of endometrial extracellular matrix in patients with unexplained infertility 
and recurrent miscarriages. Mol Hum Reprod, 2002. 8(12): p. 1111-6. 
24. Tan, O., et al., Tenascin is highly expressed in endometriosis and its expression is 
upregulated by estrogen. Fertil Steril, 2008. 89(5): p. 1082-9. 
25. Xu, Y., et al., The co-expression of MMP-9 and Tenascin-C is significantly associated 
with the progression and prognosis of pancreatic cancer. Diagn Pathol, 2015. 10: p. 
211. 
26. Ammala, M., et al., Effect of intrauterine contraceptive devices on cytokine messenger 
ribonucleic acid expression in the human endometrium. Fertil Steril, 1995. 63(4): p. 
773-8. 
27. Archer, D.F., K.R. DeSoto, and J.M. Baker, Interleukin-6 and tumor necrosis factor-
alpha concentrations in the intrauterine cavity of postmenopausal women using an 
intrauterine delivery system releasing progesterone. A possible mechanism of action of 
the intrauterine device. Contraception, 1999. 59(3): p. 175-9. 
28. Bayer-Garner, I.B. and S. Korourian, Plasma cells in chronic endometritis are easily 
identified when stained with syndecan-1. Mod Pathol, 2001. 14(9): p. 877-9. 
29. Bayer-Garner, I.B., J.A. Nickell, and S. Korourian, Routine syndecan-1 
immunohistochemistry aids in the diagnosis of chronic endometritis. Arch Pathol Lab 
Med, 2004. 128(9): p. 1000-3. 
30. Seval, M.M., et al., Does adding endometrial scratching to diagnostic hysteroscopy 
improve pregnancy rates in women with recurrent in-vitro fertilization failure? Gynecol 















Age Range (mean) 35-48 (42.75) 28-45 (37.6) p= 0.05!  
28-33 0 3 p=0.035$  
 34-39 4 7 
 40-45 8 5 
 45-49 4 0 
Ever Pregnant   16 (100%) 12 (80%) p=0.203$ 
Ever had a Live 
Birth  
 16 (100%) 11 (73.3%) p=0.086$ 
# live births median 
(interquartile 
range) 
 2.5 (2-3) 2.0 (0-2) p=0.049^ 
No longer seeking 
pregnancy 
 16 (100%) 10 (66%) p= 0.018$ 
Contraceptive # (%) Other 6 (37.5%) 9 (60%) p=0.149$ 
 Pill 4 (25%) 5 (33.3%) 





Y 6 (37.5%) 6 (40.0%) p=0.589$  
N 10 (62.5%) 9 (60.0%) 
History of 
miscarriage 
Y 8 (50.0%) 5 (33.3%) p=0.283$ 
N 8 (50.0%) 10 (66.7%)  
! t test; $ Fishers exact chi-square; ^Wilcoxon rank sum test 
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